cadherin 5
|
|
- $352 - $881
- Product name: cadherin 5
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:cadherin 5;7B4 antigen;ANTI-VE CADHERIN (CDH5) (N-TERM) antibody produced in rabbit;CD_antigen=CD144;CDH5;Vascular endothelial cadherin;Recombinant Human CD144/CDH5 Protein, His Tag
5 prices
Selected condition：
Brand
- Sigma-Aldrich
- Usbiological
Package
- 10ug
- 200ul
- 96Tests
- 400μl
- ManufacturerSigma-Aldrich
- Product numberSAB1306131
- Product descriptionANTI-VE CADHERIN (CDH5) (N-TERM) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
- Packaging400μl
- Price$481
- Updated2024-03-01
- Buy
- ManufacturerUsbiological
- Product number153752
- Product descriptionCadherin 5
- Packaging10ug
- Price$352
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number151625
- Product descriptionCadherin 5
- Packaging200ul
- Price$442
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number023825
- Product descriptionCadherin 5
- Packaging96Tests
- Price$684
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number152354
- Product descriptionCadherin 5
- Packaging96Tests
- Price$881
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Sigma-Aldrich | SAB1306131 | ANTI-VE CADHERIN (CDH5) (N-TERM) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 400μl | $481 | 2024-03-01 | Buy |
| Usbiological | 153752 | Cadherin 5 | 10ug | $352 | 2021-12-16 | Buy |
| Usbiological | 151625 | Cadherin 5 | 200ul | $442 | 2021-12-16 | Buy |
| Usbiological | 023825 | Cadherin 5 | 96Tests | $684 | 2021-12-16 | Buy |
| Usbiological | 152354 | Cadherin 5 | 96Tests | $881 | 2021-12-16 | Buy |
Properties
storage temp. :-20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|